Vaccines Federal Implementation Plan, Request for Comments; Correction, 13301 [2022-04937]

Download as PDF Federal Register / Vol. 87, No. 46 / Wednesday, March 9, 2022 / Notices HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2022–04980 Filed 3–8–22; 8:45 am] inadvertently omitted the weblink where the implementation plan is located and can be found at https:// www.hhs.gov/vaccines/vaccinesnational-strategic-plan/vaccinesfederal-implementation-plan/ index.html#:∼:text=The%20Vaccines %20Federal%20Implementation %20Plan%20outlines%20specific %20actions%20that%20federal, National%20Strategic%20Plan %202021%2D2025.&text=The %20public%20comment%20period %20for,2%2C%202022%20at%209 %20a.m. Dated: March 2, 2022. David Kim, Director, Division of Vaccines, Office of the Assistant Secretary for Health. BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2022–04937 Filed 3–8–22; 8:45 am] BILLING CODE 4150–44–P Vaccines Federal Implementation Plan, Request for Comments; Correction DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice; correction. AGENCY: National Institutes of Health Center for Scientific Review; Notice of Closed Meetings The Office of the Assistant Secretary for Health published a document in the Federal Register of March 2, 2022, announcing the request for comments for the Vaccines Federal Implementation Plan. The document includes a weblink where the Vaccines Federal Implementation Plan can be found: https://www.hhs.gov/vaccines/ vaccines-national-strategic-plan/ vaccines-federal-implementation-plan/ index.html#:∼:text=The%20Vaccines %20Federal%20Implementation %20Plan%20outlines%20specific %20actions%20that%20federal, National%20Strategic%20Plan %202021%2D2025.&text=The %20public%20comment%20period %20for,2%2C%202022%20at%209 %20a.m. SUMMARY: Dr. David Kim, Director, Division of Vaccines, U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, Room L616, Switzer Building, 330 C St. SW, Washington, DC 20024. Phone: 202– 795–7697; Email: nvp.rfi@hhs.gov. SUPPLEMENTARY INFORMATION: jspears on DSK121TN23PROD with NOTICES1 FOR FURTHER INFORMATION CONTACT: Correction In the Federal Register of March 2, 2022, in FR Doc. 2022–04327, on page 11724, in the second column, correct the subject line Meeting of the Vaccines Federal Implementation Plan to read, ‘‘Vaccines Federal Implementation Plan, Request for Comments’’. We also VerDate Sep<11>2014 17:44 Mar 08, 2022 Jkt 256001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Neurodegeneration and Drug Discovery. Date: April 5, 2022. Time: 12:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Christine Jean DiDonato, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1014J, Bethesda, MD 20892, (301) 435–1042, didonatocj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: International and Cooperative Projects for Global Emerging Leaders Award. Date: April 6, 2022. Time: 9:30 a.m. to 6:00 p.m. PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 13301 Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Seetha Bhagavan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 20892, (301) 237– 9838, bhagavas@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Special Topics: Micro Physiological Systems and Implanted Devices. Date: April 6, 2022. Time: 12:00 p.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Robert C. Elliott, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3130, MSC 7850, Bethesda, MD 20892, (301) 435– 3009, elliotro@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Transplantation and Autoimmunity. Date: April 6, 2022. Time: 12:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Shiv A. Prasad, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD 20892, (301) 443– 5779, prasads@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 4, 2022. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–04984 Filed 3–8–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the E:\FR\FM\09MRN1.SGM 09MRN1

Agencies

[Federal Register Volume 87, Number 46 (Wednesday, March 9, 2022)]
[Notices]
[Page 13301]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04937]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Vaccines Federal Implementation Plan, Request for Comments; 
Correction

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Office of the Assistant Secretary for Health published a 
document in the Federal Register of March 2, 2022, announcing the 
request for comments for the Vaccines Federal Implementation Plan. The 
document includes a weblink where the Vaccines Federal Implementation 
Plan can be found: https://www.hhs.gov/vaccines/vaccines-national-
strategic-plan/vaccines-federal-implementation-plan/
index.html#:~:text=The%20Vaccines%20Federal%20Implementation%20Plan%20ou
tlines%20specific%20actions%20that%20federal,National%20Strategic%20Plan
%202021%2D2025.&text=The%20public%20comment%20period%20for,2%2C%202022%2
0at%209%20a.m.

FOR FURTHER INFORMATION CONTACT: Dr. David Kim, Director, Division of 
Vaccines, U.S. Department of Health and Human Services, Office of the 
Assistant Secretary for Health, Room L616, Switzer Building, 330 C St. 
SW, Washington, DC 20024. Phone: 202-795-7697; Email: [email protected].

SUPPLEMENTARY INFORMATION:

Correction

    In the Federal Register of March 2, 2022, in FR Doc. 2022-04327, on 
page 11724, in the second column, correct the subject line Meeting of 
the Vaccines Federal Implementation Plan to read, ``Vaccines Federal 
Implementation Plan, Request for Comments''. We also inadvertently 
omitted the weblink where the implementation plan is located and can be 
found at https://www.hhs.gov/vaccines/vaccines-national-strategic-plan/
vaccines-federal-implementation-plan/
index.html#:~:text=The%20Vaccines%20Federal%20Implementation%20Plan%20ou
tlines%20specific%20actions%20that%20federal,National%20Strategic%20Plan
%202021%2D2025.&text=The%20public%20comment%20period%20for,2%2C%202022%2
0at%209%20a.m.

    Dated: March 2, 2022.
David Kim,
Director, Division of Vaccines, Office of the Assistant Secretary for 
Health.
[FR Doc. 2022-04937 Filed 3-8-22; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.